Thomas Elung‐Jensen

Moderate Antiproteinuric Effect of Add-On Aldosterone Blockade with Eplerenone in Non-Diabetic Chronic Kidney Disease. A Randomized Cross-Over Study

Lene Boesby, Thomas Elung‐Jensen, Tobias Wirenfeldt Klausen et al. · PLoS ONE · 2011 · 47 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +16

Eplerenone Attenuates Pulse Wave Reflection in Chronic Kidney Disease Stage 3–4 - A Randomized Controlled Study

Lene Boesby, Thomas Elung‐Jensen, Svend Strandgaard et al. · PLoS ONE · 2013 · 40 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Retraining for prevention of peritonitis in peritoneal dialysis patients: A randomized controlled trial

Susanne Ljungman, J Jensen, Dag Paulsen et al. · Peritoneal Dialysis International · 2020 · 30 citations · Full text

Medicine, Preventive Medicine, Dialysis +13

Longitudinal observations on circadian blood pressure variation in chronic kidney disease stages 3-5

Thomas Elung‐Jensen, S. Strandgaard, Anne‐Lise Kamper · Nephrology Dialysis Transplantation · 2008 · 29 citations

Medicine, Internal Medicine, Nephrology +17

Silencing of Renal DNaseI in Murine Lupus Nephritis Imposes Exposure of Large Chromatin Fragments and Activation of Toll Like Receptors and the Clec4e

Dhivya Thiyagarajan, Silje Fismen, Natalya Seredkina et al. · PLoS ONE · 2012 · 28 citations · Full text

Life Sciences, Immunology, Pathology +17